About Us

Arena (ARNA) Q4 Misses Expectations

Arena Pharmaceuticals, Inc. (ARNA) shares are down $0.08 to $4.20 in extended hours Monday after the company reported its fourth quarter earnings results. The biopharmaceutical company reported earnings of ($0.15) per share on revenues of $9.2 million, up 41.5% from a year ago. Analysts were expecting EPS of ($0.11) on revenues of $11.01 million. For full-year […] View the full post at: Arena (ARNA) Q4 Misses Expectations Related posts: JPMorgan Posts Better-than-Expected Results Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.